CD4 and myeloid sarcoma: Within the MS group, the proportions of both T‐bet+ and CXCR3+ B cells were markedly reduced in people with advanced progressive versus early relapsing disease (Figure 2A,B; Figure S2C,D), a pattern not observed for CD4+ memory T cells (Figure S3A,B).